Roundup: ExxonMobil sale / Single-dose vaccine / Amtrak returning

Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.

North Sea assets: ExxonMobil is selling most of its upstream assets in the United Kingdom central and northern North Sea to HitecVision for more than $1 billion. The sale includes ExxonMobil’s interests in 14 producing fields in the U.K. North Sea. ExxonMobil’s share of production from these fields was approximately 38,000 oil-equivalent barrels per day in 2019. The Irving, Texas-based oil company, which has operated in the U.K. for more than 135 years, is still keeping extensive refining and fuels marketing, lubricants, petrochemicals production and the natural gas marketing business in the U.K. Read the full story.  

Awaiting FDA approval: An analysis by U.S. regulators say Johnson & Johnson’s single-dose vaccine protects against COVID-19 and is about 66% effective at preventing moderate to severe illness. On Friday, a panel of experts to the Food and Drug Administration will debate if the evidence is strong enough to recommend the vaccine. The FDA is expected to make a final decision within days. If the FDA clears the J&J shot for U.S. use, it won’t boost vaccine supplies significantly right away. Only a few million doses are expected to be ready for shipping in the first week. Read the full story. 

Gulf Coast service: Amtrak passenger service along the Gulf Coast is on track to return in 2022—and could come in the early part of next year, a company official says. The route will connect Mobile, Alabama, to New Orleans, with four stops in Mississippi: Bay St. Louis, Gulfport, Biloxi and Pascagoula. It will mark the first time that passenger trains have rolled along the Gulf Coast in more than 16 years. Read the full story.   

Advertisement

 

Discussion (0)

From Our Partners

Daily Report Poll

ASK AI

Ask anything about Baton Rouge business